Colm Fagan
Registered User
- Messages
- 712
Colm, the first 4 helpings of this product stated that they backtested the Solactive European Deep Value Select 50 Index over 1,304 times starting in 2009 and found that on all 1,304 occasions it finished above its initial level after 5 years and so 40% was the minimum return on 100% of backtests.@elacsaplau Brian and I shared our concerns with the regulators. It's up to them to decide what to do. Obviously, it's not the job of the regulator to prevent poor value products from being sold. Financial advisers have a vitally important role to play, analysing products to see if they offer good value for their clients. If they can't do that analysis, are they in the right business?
I'm not the greatest fan of the regulator, but it's not their responsibility to do the job of the financial adviser. The adviser gets paid for researching the market, checking the claims of the various providers and deciding whether a product is suitable for clients. The back-test results for this product are presumably correct in so far as they go, and the brochure states that the past is not a reliable guide to the future. Nothing wrong in all of this. The index is one of the weirdest creations I've ever seen and caused alarm bells to ring immediately I saw it. Should an adviser be able to pick this up? You tell me.The Regulator has a definite consumer protection responsibility so this, very much, is the job of the Regulator to sort out, as described.
Mel, in the interest of disclosure of any conflicts, is this a product you've been selling to clients?Please ask for clarification on a product from its producers before you jump to inaccurate conclusions.
I'm not the greatest fan of the regulator
Hello Red Onion, in the interest of disclosure and transparency, I don't divulge my firms' business dealings and practices with people who are not disclosed and transparent but I will say this, since the last financial crisis, I would give any financial instrument serious consideration which had an 85% level of capital protection from a financial institution with the balance sheet of BNP Paribas.Mel, in the interest of disclosure of any conflicts, is this a product you've been selling to clients?
So you don't like me saying that the adviser should research the market, check the claims of the various providers and decide whether a product is suitable for clients. Interesting.I don't like the rest of your post much, however
.. even if independent experts have assessed the chances of making money from the product at about 1 in 6? Interesting too.I would give any financial instrument serious consideration which had an 85% level of capital protection from a financial institution with the balance sheet of BNP Paribas.
….relation to the creation and distribution of this product
Wow! There's someone who's upset. We spoke to the CBI about a number of aspects, one of the key ones being the back-testing which showed a 1,304/1,304 success rate and a worst back-testing result of +40%. That was Series 4 (and all other series, I think). Series 5, which is essentially the same product, shows a 1779/2609 success rate and a worst result of -16%. I hope that our intervention contributed to the change in presentation of back-testing results. A change in the right direction.
@elacsaplau Brian and I shared our concerns with the regulators. It's up to them to decide what to do. Obviously, it's not the job of the regulator to prevent poor value products from being sold. Financial advisers have a vitally important role to play, analysing products to see if they offer good value for their clients. If they can't do that analysis, are they in the right business?
Mel, you're new in these parts, welcome to the bear pitOne final comment from experience, it is a regulatory obligation to back test a product on a daily template, yes daily.
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?